Market Segmentation

• Offering– Product (Kits and Assays and Software) and Service
• Application– Translational Research and Diagnostics (Colorectal Cancer, Cervical Cancer, Oral Cancer, and Other Cancer Types)
• Technology – Next-Generation Sequencing (Sequencing by Synthesis, Sequencing by Ligation, and Other Next-Generation Sequencing Technologies) and Polymerase Chain Reaction
• End User – Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, and Other End Users

Regional Segmentation

• North America – U.S., and Canada
• Europe – Germany, France, U.K., Spain, Italy, Switzerland, and Rest-of-Europe
• Asia-Pacific – China, Japan, India, Australia, South Korea, Singapore, and Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, and Rest-of-Latin America
• Rest-of-the-World

Market Growth Drivers

• Increasing Emphasis on the Microbiome’s Potential in the Field of Cancer
• Global Increase in Cancer Prevalence
• Decreasing Cost of Sequencing

Market Challenges

• Regulatory Challenges for Direct-to-Consumer (DTC) Companies
• Lack of High Complexity Testing Centers
• Existing Diagnostic Confidence on Conventional Cancer Diagnostics

Market Opportunities

• Growing Integrative Industry-Academia Collaboration
• Massive Scope for Adoption of Cancer Microbiome Sequencing in Developing Nations

Key Companies Profiled

CD Genomics, Eurofins Scientific, GoodGut, Illumina, Inc., Prescient Medicine Holdings, Inc., Micronoma Inc., Novogene Co., Ltd., Oxford Nanopore Technologies plc., OraSure Technologies, Inc., Pacific Biosciences of California, Inc., Psomagen, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., Viome, Inc., Zymo Research Corporation

Key Questions Answered in this Report:

• How is cancer microbiome sequencing revolutionizing the field of oncology?
• What are the major market drivers, challenges, and opportunities in the global cancer microbiome sequencing market?
• What are the underlying structures resulting in the emerging trends within the global cancer microbiome sequencing market?
• How did the COVID-19 pandemic impact the global cancer microbiome sequencing ecosystem?
• What are the key development strategies that are being implemented by the major players in order to sustain themselves in the competitive market?
• What are the key regulatory implications in developed and developing regions pertaining to the use of cancer microbiome sequencing?
• What are the potential entry barriers, which are expected to be faced by the companies willing to enter a particular region?
• How is each segment of the market expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each of the segments? Following are the segments:
o Offering (product and service)
o Application (translational research and diagnostics)
o Technology (next-generation sequencing and polymerase chain reaction)
o End User (academic and research institutes, pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, and other end users)
o Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
• What are the growth opportunities for the cancer microbiome sequencing companies in the region of their operation?
• Who are the leading players with significant offerings in the global cancer microbiome sequencing market?
• Which companies are anticipated to be highly disruptive in the future, and why?

Market Overview

Our healthcare experts have found the cancer microbiome sequencing industry to be one of the most rapidly evolving and dynamic markets, and the global market for cancer microbiome sequencing is predicted to grow at a CAGR of 20.01% over the forecast period of 2021-2031.

The market is driven by certain factors, including increasing emphasis on the microbiome’s potential in cancer, global increase in cancer prevalence, and decreasing cost of sequencing.

Currently, the cancer microbiome sequencing industry is witnessing an upsurge due to the increasing emphasis on the microbiome’s potential in the field of cancer, global increase in cancer prevalence, and decreasing cost of sequencing.

Furthermore, biotechnology companies are focusing on developing cancer microbiome sequencing solutions for applications, including translational research and diagnostics, further supporting researchers and clinicians to unravel insights pertaining to microbiome’s influence on cancer manifestation and progression.

The development of cancer microbiome sequencing products and services enabled the research community to establish effective strategies for discovering novel cancer biomarkers associated with the microbiome, which could be harnessed for the development of cancer microbiome sequencing products for clinical use.

Within the research report, the market is segmented on the basis of offering, application, technology, end users, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The exponential rise in the number of cancer cases worldwide has created a buzz among the biotechnology companies to further invest in the development of novel diagnostic tools based on microbiome for supporting physicians to offer early cancer detection. Due to the expansive product portfolio and massive geographical presence, Illumina, Inc. has been the leading player in the cancer microbiome sequencing ecosystem.

On the basis of region, North America holds the largest share of the cancer microbiome sequencing market due to the presence of market leaders such as Illumina, Inc. in the U.S. coupled with the significant adoption of high-fidelity cancer microbiome sequencing products and services for translational research.

Further, rising fund infusions by the federal organizations and increasing investments for product development, among others. Apart from this, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period, 2021-2031. This is majorly attributed to the underlying factors such as an increase in healthcare awareness, steady economy leading to higher focus on research, and widespread adoption of advanced cancer diagnostics, among others.

Related Reports: Global Bladder Cancer Detection Kit Market Analysis and Forecast Report 2030

The post Cancer Microbiome Sequencing Market – A Global and Regional Analysis: Focus on Offering, Application, Technology, End User, and Region – Analysis and Forecast, 2021-2031 first appeared on CRI Report.

Market Segmentation

• Platform: Satellite, Launch Vehicles

• End User: Government and Military, Commercial

• Material: Carbon Fiber, Aluminium and Titanium Alloys, Thermoset and Thermoplastic, Nanomaterials, Others

• Manufacturing Process: Automated Fiber Placement (ATL/AFP), Compression Molding, Additive Manufacturing, Conventional Manufacturing, Others

• Propellant Tank Type: Diaphragm Tanks, Propellant Management Devices, Helium, Nitrogen, and Xenon Tanks, Aluminium Alloy Tanks

Regional Segmentation

• North America: U.S., Canada

• Europe: Germany, U.K., France, Russia, Rest of Europe

• Asia-Pacific: Japan, China, India, Rest-of-Asia-Pacific

• Rest-of-the-World: Middle East and Africa, Latin America

Market Growth Drivers

• Rapid Escalation of the Production and Launch of Satellites

• Rising Research and Development Activities to Develop Cost-Efficient Propellant Tank for Satellites and Launch Vehicles

Market Challenges

• High Cost Associated with Large Space-qualified Propellant Tank

Market Opportunities

• Growing Developments for Deep Space Exploration Programs

Key Companies Profiled

Airbus S.A.S, Adam Works, Ariane Group, Busek Co Inc., Cobham Mission System, Infinite Composites Technologies, IHI Aerospace Co., Lockheed Martin Corporation, Microcosm, Inc., Moog Inc., OHB SE, Northrop Grumman Corporation, Nammo AS, Peak Technology, Stelia Aerospace North America Inc.

How This Report Can Add Value

This exclusive report on space qualified propellent tank market will help you with:

• A dedicated section focusing on the futuristic trends adopted by the key players operating in the global space-qualified propellant tank market.

• Extensive competitive benchmarking of top 15 players (including OEMs and component providers) offering a holistic view of the global space-qualified propellant tank landscape

• Detailed qualitative and quantitative mapping of satellites and launch vehicles from 2020-2031.

• Qualitative and quantitative analysis of space-qualified propellant tank at the region and country-level granularity by application and product segments.

Market by Product: Analysis and Forecast: The product segment helps the reader in understanding the different types of space-qualified propellant tank and their market potentials globally.

Moreover, the study provides the reader a detailed understanding of space-qualified propellant tank with respect to platform type (satellite, launch vehicle), end user (government and military, commercial), material (carbon fiber, aluminum and titanium alloys, thermoset and thermoplastic,

nanomaterials and others), manufacturing process (automated fiber placement, compression molding, additive manufacturing, conventional manufacturing), propellant tank type (diaphragm tanks, propellant management devices, helium, nitrogen, and xenon tanks, and aluminum alloy tanks).

Market by Application: Analysis and Forecast: The space qualified propellent tank market by application is majorly driven by end user applications, including government, military, and commercial uses. For instance, in January 2021, Airbus and Thales signed a contract with the European Commission of $1.79 billion for the development of 12 satellites. Both the companies would provide end-to-end solutions in manufacturing these satellites.

Similarly, in April 2020, Infinite Composite Technologies introduced the first-ever spherical Type V cryotank for storing the cryogenic propellants for launch vehicles and spacecraft such as lunar landers.

Key Questions Answered in the Report

• What are the futuristic trends in this market, and how is the market expected to change over the forecast years, 2021-2031?

• What are the key drivers and challenges faced by the companies currently working in the global space-qualified propellant tank market?

• How is the space-qualified propellant tank market expected to grow during the forecast period 2021-2031?

• What are the opportunities for the companies to expand their businesses in the global space-qualified propellant tank market?

• Which region is expected to lead the global space-qualified propellant tank market by 2031?

• What are the key developmental strategies implemented by the key players to sustain in this highly competitive market?

• What is the current and future revenue scenario of this market?

• What is the competitive scenario of the key players in the global space-qualified propellant tank market?

• What are the emerging technologies that the key companies are focusing on to increase their market share?

• What are the strengths and weaknesses of the companies that are influencing the growth of the market?

Space-qualified Propellant Tank

Propellant tanks are used in satellites and launch vehicles for storing liquid fuels. Additionally, a cryogenic rocket propellant tank (cryo-tank) is used for storing fuel or oxidizer of rocket stages. The upcoming space heavy-lift launch vehicles demand extremely excessive propellant mass fractions to obtain the designed performance set by the existing metallic tanks. This is driving companies to develop lightweight propellant tanks.

Between 1957 and 2021, many governments and commercial organizations such as Infinite Composite Technologies, Ariane Space, Europe Space Agency (ESA), National Aeronautics and Space Administration (NASA), and Japan Aerospace Exploration Agency (JAXA), started demonstrations for new propellant tank for different satellites and launch vehicles.

Since then, the technology has evolved continually and transformed the entire space industry by developing unique products and systems.

Currently, many space agencies and commercial companies across the globe have been focusing on developing satellite constellations. This is expected to drive the market for the propellant tank system.

Space-qualified Propellant Tank Industry Overview

The global space-qualified propellant tank market is expected to reach $3,069.5 million by 2031, with a CAGR of 4.83% during the forecast period 2021-2031. The rapid escalation of the production and launch of satellites is expected to be the major driving factor for the market. In addition, rising demand for building efficient propellant tanks at low cost are key drivers for the growth of the global space-qualified propellant tank market.

Market Segmentation

Space-qualified Propellant Tank Market by Platform

The satellite platform segment is estimated to dominate the global space-qualified propellant tank market due to the rising development of satellite constellations for communication, Earth observation, navigation, and tracking purposes.

Space-qualified Propellant Tank Market by End User

The commercial end user segment is estimated to dominate the global space-qualified propellant tank market due to the rising development of small satellite constellations for communication, remote sensing, Earth observation, and navigation by commercial industries.

Space-qualified Propellant Tank Market by Material

Carbon Fiber material is the most prominent material contributing to the global space-qualified propellant tank market. The space industry has been using carbon fiber composites for manufacturing satellite structures and launch vehicle structures.

For instance, for NASA’s Artemis Program Space Launch System (SLS), a heavy launch vehicle, rocket parts were manufactured using the automated fiber placement (AFP) machine. These rocket parts comprised sandwich structures of more than eight meters in diameter made of carbon fiber skins with an aluminum honeycomb core.

Space-qualified Propellant Tank Market by Manufacturing Process

Space will continue to be a major source of applications for compression molded composite parts. Compression molding using BMC is an enabling technology for the fabrication of complex composite parts for aerostructures, space, and satellites.

Space-qualified Propellant Tank Market by Propellant Tank Type

With the growing number of space-qualified propellant tanks, it is anticipated that the requirement for diaphragm tanks will grow in the upcoming years. The tanks are light in weight, reliable, and manufactured at low cost, which has proliferated their use in the aerospace sector over the years. The tanks are replacing titanium propellant tanks that were previously used for spacecraft application due to their low cost and simple design.

Space-qualified Propellant Tank Market by Region

North America is expected to account for the highest share of the global space-qualified propellant tank market, owing to a significant number of companies based in the region, increased spending by government and commercial organizations such as the National Aeronautics and Space Administration (NASA), Lockheed Martin, Ariane Group, Northrop Grumman, Microcosm, and Stelia Aerospace North America for space-qualified propellant tank.

Key Market Players and Competition Synopsis

Some of the key players operating in the market include Airbus S.A.S, Adam Works, Ariane Group, CU Aerospace, Northrop Grumman Corporation, Nammo AS, OHB SE, Peak Technology, and Stelia Aerospace North America Inc., among others.

The companies profiled in the report have been selected post-in-depth interviews with experts and understanding details around companies such as product portfolios, annual revenues, market penetration, research and development initiatives, and domestic and international presence in the space-qualified propellant tank market.

Accordingly, a structured approach has been followed, which includes segmenting the pool of players under three mutually exclusive and collectively exhaustive parts, holding a 100% pie of the market, as mentioned below:

Top Segment Players – These are leading original equipment manufacturers (OEMs), covering ~90% of the presence in the market.

Other Segment Players – These are component providers, covering ~10% of the presence in the market.

However, if a company is not part of the above pool, it has been well represented across different sections of the report (wherever applicable).

Aerospace Cold Forgings Market: Global Analysis of Market Size, Share & Trends for 2019–2020 and Forecasts to 2030

The post Space-qualified Propellant Tank Market: Analysis and Forecast, 2021-2031 first appeared on CRI Report.

Market Segmentation

• Product Type – Reagents and Consumables, Kits and Services

• Application – Structural Chromosomal Abnormalities, Single Gene Disorder and Others

• Technology – Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), In Situ Hybridization (ISH/FISH), Microarray

• End User – Diagnostic Center, Research Center, and Others

Regional Segmentation

• North America – U.S., Canada

• Europe – France, Italy, U.K., Spain, Netherlands, Russia, and Rest-of-Europe

• Asia-Pacific – China, Japan, India, South Korea, Australia, and Rest-of-Asia-Pacific (RoAPAC)

• Rest-of-the-World

Market Growth Drivers

• Advancing Maternal Age Globally

• A Rise in Adoption of In-Vitro Fertilization

• Increasing Awareness for Genetic Testing

• Rising Emphasis on Predictive Genetic Testing for Early Detection

Market Challenges

• Ethical Issues Pertaining to the Preimplantation Genetic Testing

• High Procedural Cost Associated with Preimplantation Genetic Testing

Market Opportunities

• Decreasing Cost of Genomic Sequencing

• The Emergence of Reproductive Tourism

Key Companies Profiled

Abbott Laboratories, Agilent Technologies, Inc., BGI, Fulgent Genetics, Inc., Igenomix, Illumina, Inc., Invitae Corporation, Myriad Genetics, Inc., MedGenome Labs Ltd., Natera, Inc., PerkinElmer, Inc., Pac Genomics, Thermo Fisher Scientific Inc.

Key Questions Answered in this Report:

• What are the factors necessitating the requirement of global preimplantation genetic testing globally?

• What are the different types of products available in the global preimplantation genetic testing market?

• What are the key development strategies implemented by the key players to stand out in this global preimplantation genetic testing market?

• What are the various technologies deployed within the global preimplantation genetic testing market?

• How have the strategic collaborations among the key players provided a push to product development within the global preimplantation genetic testing market?

• Which are the leading companies that are dominating the global preimplantation genetic testing market?

• Based on the application type, which therapy in the global preimplantation genetic testing market is anticipated to witness a massive rise in demand during the forecast period?

• How is each segment of the global preimplantation genetic testing market expected to grow during the forecast period, and what revenue will be generated by each segment by the end of 2031?

Market Overview

Preimplantation genetic diagnosis (PGD) is performed among couples that have a higher risk of transmitting a genetic condition to their offspring. The technique is employed in in-vitro fertilization centers globally to select the euploid embryos to transfer and improve the clinical outcome of the clinical pregnancy, embryo implantation, and live birth rates.

The ability to identify the preimplantation embryos with the genetic defects prior to the initiation of the pregnancy also offers an attractive alternative to chorionic villous sampling or amniocentesis.

The preimplantation genetic testing is set to grow at a significant rate in the upcoming years as the technology and awareness regarding the test improve.

The global preimplantation genetic testing market was valued at $972.1 million in 2020 and is expected to reach $2,725.7 million by 2031, registering a CAGR of 9.69% during the forecast period 2021-2031.

The growth is attributed to the advancing maternal age globally, rising adoption of in-vitro fertilization, increasing awareness of genetic testing, and rising emphasis on predictive testing. Further, continued significant investments by biotechnology firms to improve the technology for genetic testing and to improve affordability have also promoted the prominence of preimplantation genetic testing.

Within the research report, the market is segmented based on product, application, end user, technology, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The exponential rise in the usage of in-vitro fertilization facilities as an option for healthy childbirth and increasing affordability for genetic testing on a global level has created awareness as well as demand among consumers, which has eventually led to the companies to invest in the development of more such preimplantation genetic test.

The companies such as Agilent Technologies, Inc. and Natera, Inc. have been incorporating major strategies to enhance their market presence via key developments. The other major contributors to the market include companies such as Thermo Fisher Scientific, PerkinElmer, Inc., Invitae Inc., and Igenomix.

Based on region, North America holds the largest share of the preimplantation genetic testing market due to eased regulatory scenario and a large number of IVF facilities offering such PGT tests.

Further, substantial investments made by biotechnology companies to improve the genetic testing facilities and advancing technologies along with the rise in per capita income in the region are also fuelling the growth of the respective market. Apart from this, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period.

Global Adult Hemoglobinopathy Testing Market 2029

The post Preimplantation Genetic Testing Market-Analysis and Forecast, 2021-2031 first appeared on CRI Report.

Market Segmentation

• Product Type – Continuous Positive Airway Pressure Device (CPAP), Automatic Positive Airway Pressure Device (APAP), Bi-Level Positive Airway Pressure Device (BiPAP)
• Indication – Sleep Apnea, Chronic Obstructive Pulmonary Disease (COPD), Others
• End User – Sleep Laboratories, Home Care, Others (Hospitals and Clinics, Elderly Care Homes, Nursing Homes, etc.)

Regional Segmentation

• North America – U.S. and Canada
• Europe – Germany, U.K., France, Italy, Spain, Nordic Countries, and Rest-of-Europe
• Asia-Pacific – Japan, China, India, Australia and New Zealand, South Korea, and the Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, Argentina, Colombia, and the Rest-of-Latin America
• Middle East and Africa – K.S.A., U.A.E., South Africa, and the Rest-of-Middle East and Africa

Market Growth Drivers

• Rising Number of Startups Driving Innovation
• Increasing Prevalence of Obstructive Sleep Apnea
• Growing Prevalence of Respiratory Diseases among the Geriatric Population
• Growing Prevalence of Chronic Respiratory Diseases across the Globe

Market Challenges

• High Upfront Cost of the Devices
• Side-Effects Associated with Long-Term Usage

Market Opportunities

• Development of Smart PAP Devices
• Deployment of 3D Scanning to Offer Customized PAP Masks
• Development of Accessory-Free PAP Devices

Key Companies Profiled

3B Medical, Inc, Apex Medical Corporation, BMC Medical Co. Ltd., Breas Medical AB, Compumedics Limited, Drive DeVilbiss Healthcare, Elmaslar Group, Fisher & Paykel Healthcare Corporation Limited, Hebei Topson Medical Technology Co., Ltd.,

Kare Medical and Analytical Devices Ltd. Co., Koninklijke Philips N.V., Löwenstein Medical Technology GmbH + Co. KG., Narang Medical Limited, ResMed Inc., Somnetics International, Inc.

How This Report Can Add Value

Assuming that the reader is a manufacturer of positive airway pressure devices, they will be able to do the following:

• Understand their position as compared to some of the key players in the market
• Get information on parameters such as device adoption rate, therapy compliance rate, and discontinuation rate
• Assess the disease epidemiology in each region
• Familiarize themselves with the necessary information related to changing market dynamics
• Stay updated with the latest trends in the market with respect to connected devices
• Understand the impact of COVID-19 on the market
• Identify some of the key players in the market and understand their value contribution

Key Questions Answered in the Global Positive Airway Pressure Devices Market Report:

• How has COVID-19 impacted the adoption of PAP devices in the market?
• What are the key regulations which influence the adoption of PAP devices in the market?
• What are some of the key companies in the global and regional PAP market?
• What are some of the key factors influencing the growth in adopting PAP devices across the globe?
• What are some of the growth opportunities which market players can capitalize on?
• What is the PAP device adoption rate for patients diagnosed with sleep apnea?
• What are the compliance and discontinuation rates for PAP therapy across regions?
• What are the fastest-growing countries in terms of PAP devices adoption?
• Which are the key diseases driving the adoption of PAP devices across the world?
• What are the key strategies being adopted by market players in the global positive airway pressure devices market?
• Who are the most common end-users of PAP devices, and how are the end-use segment expected to grow in the future?

Positive Airway Pressure Devices Market Industry Overview

A positive airway pressure delivery system is a prescription non-invasive ventilatory device that delivers expiratory positive airway pressure for patients suffering from obstructive sleep apnea. The system also provides positive airway pressure during incipient apnea.

The system may include a dedicated flow generator and a patient interface.

Sleep apnea is a sleep-related breathing disorder that involves a decrease or complete halt in airflow despite an ongoing effort to breathe. It occurs when the muscles relax during sleep, causing the soft tissue at the back of the throat to collapse and block the upper airway.

Obstructive sleep apnea is also one of the independent risk factors for stroke, cardiovascular diseases, and systemic hypertension, among other clinical consequences. Globally, sleep apnea impacts more than 936 million individuals worldwide.

The American Academy of Sleep Medicine (AASM) recommends that continuous positive airway pressure (CPAP) devices be considered first-line treatment for moderate and severe OSA.

Despite the recommendations, CPAP devices and PAP devices in general frequently encounter challenges in terms of adherence. There are a number of factors that contribute to the low adherence rates for PAP devices.

These factors primarily include claustrophobia, discomfort, and high cost. Several studies have been conducted to identify the reason behind low adherence rates despite several changes in the device and mask dynamics.

The global positive airway pressure devices market report highlights that the market was valued at $3,411.5 million in 2020 and is expected to reach $6,218.5 million by the end of 2030. The market is expected to grow at a CAGR of 6.03% during the forecast period from 2021 to 2030.

Global Positive Airway Pressure Devices Market Drivers

Currently, the market is mainly being driven by the growing prevalence of obstructive sleep apnea and chronic respiratory diseases.

Some countries have registered increasing awareness of the benefits of positive airway pressure (PAP) therapy, and as a result, there has been a hike in the prevalence of PAP therapy in those countries in the past few years.

There has been a steady growth in the number of health-tech startups in the industry. The market entry of new players has been further accelerated by the COVID-19 pandemic.

MedTech startups have been responding to the growing demand for ventilators by offering non-invasive unconventional systems and indigenous ventilators. Apart from that, globally, the prevalence of obstructive sleep apnea is expected to exceed 986 million cases by the end of 2026.

According to data obtained from the Global Data Health Exchange and BIS Research analysis, the incidence of the condition in North America was as high as 1 in 11 individuals in 2020. The life expectancy in most countries has surged tremendously.

The improvement in life expectancy is due to significant advancements in diagnostic technology and medical science. Furthermore, growing awareness regarding health, nutrition, and hygiene has also resulted in increased life expectancy.

The prevalence of diseases among the growing geriatric population has grown at a significant pace during 2015-2019 as compared to those aged 54 and below.

Global Positive Airway Pressure Devices Market Challenges

The primary challenge is the lack of awareness of the benefits of positive airway pressure therapy among individuals.

Sleep apnea itself faces a significant challenge in getting diagnosed with many individuals unaware that they suffer from the condition. A key restraining factor to the growth in the adoption of PAP devices is their high cost.

Additionally, the lack of reimbursement policies by the government and commercial payors also hampers the adoption of PAP devices in emerging economies. These devices are also uncomfortable for many users, which results in the discontinuation of therapy.

The global positive airway pressure devices market is also expected to be restrained due to non-adherence.

Global Positive Airway Pressure Devices Market Opportunities

Owing to the rising focus on remote patient monitoring, mobile health applications, and integration of telemedicine in treatment and diagnostic aspects of healthcare, the development of smart PAP devices offers a novel opportunity to both established and emerging players.

Established PAP device manufacturers can develop devices integrated with a mobile application that would enable patients to monitor their breathing quality, sleep quality, and therapy adherence. Moreover, the mobile application could further facilitate data sharing with a physician for patient monitoring.

For instance, Koninklijke Philips N.V. developed DreamMapper, a mobile application compatible with its CPAP devices. The mobile application offers various features such as therapy hours, educational information, progress monitoring, and data sharing with physicians.

Impact of COVID-19 on the Positive Airway Pressure Devices Industry

The impact of COVID-19 varies depending on the region, country, the extent of lockdowns, and the perception of the local population.

The market witnessed a temporary boost in demand when CPAP devices were approved for emergency use by regulatory bodies to bridge the gap between demand for and supply of ventilators.

Key areas of the supply chain were impacted during the initial days of the pandemic, which comprised coinciding lockdowns in several countries leading to a restriction in global logistics. The resulting strain led to reduced stock in warehouses and a hike in logistics costs locally.

Market Segmentation

Global Positive Airway Pressure Devices Market (by Product Type)

CPAPs are considered the gold standard for the treatment of sleep apnea.

The growth in the adoption of CPAP devices across various segments can be attributed to the rise in the prevalence of breathing difficulties, which has led to more doctors prescribing such devices. The history of CPAP therapy can be traced back to the 1950s with the commencement of early sleep studies.

The major challenge associated with recording data in that era was the lack of any digital means to implement CPAP. The use of APAP is mostly restricted to those with moderate-to-severe obstructive sleep apnea (OSA).

The main barriers to the adoption of APAP devices in the market include low diagnosis rates for those suffering from OSA. APAP devices are also priced higher than CPAP devices which are considered the gold standard therapy for OSA.

BiPAP devices have two pressure settings – inhalation PAP and exhalation PAP. Depending on the settings of the device, the switch between inhalation and exhalation can be timed or automatically based on the individual’s breathing patterns.

In some cases, BiPAP devices are considered a better option for some individuals. BiPAPs are priced much higher than CPAP and APAP devices and face low adoption rates.

Global Positive Airway Pressure Devices Market (by Indication)

Sleep apnea is the dominant indication for which positive airway pressure therapy is recommended. Sleep apnea remains undiagnosed among a significant chunk of the individuals who have it. There are several more filters which lead to low adoption rates of positive airway pressure devices.

Global Positive Airway Pressure Devices Market (by End User)

Traditionally, sleep studies were usually conducted at sleep laboratories to monitor physiological data such as heart rate, breathing, and oxygen levels to diagnose sleeping disorders.

However, owing to apprehensions regarding COVID-19 transmission, the pandemic witnessed a decline in the instances of studies conducted at these centers.

The demand created by sleep laboratories is expected to return to normal post the pandemic as patients suffering from severe OSA requiring in-clinic monitoring continue to visit sleep laboratories.

Global Positive Airway Pressure Devices Market (by Region)

The different regions covered under the global positive airway pressure devices market include North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.

North America and Europe are two of the largest markets for positive airway pressure devices, while developing countries are expected to register strong growth in the adoption of positive airway pressure devices in the near future.

Key Market Players and Competition Synopsis

Some of the key players operating in the market include 3B Medical, Inc, Apex Medical Corporation, BMC Medical Co. Ltd., Breas Medical AB, Compumedics Limited, Drive DeVilbiss Healthcare, Elmaslar Group, Fisher & Paykel Healthcare Corporation Limited,

Hebei Topson Medical Technology Co., Ltd., Kare Medical and Analytical Devices Ltd. Co., Koninklijke Philips N.V., Löwenstein Medical Technology GmbH + Co. KG., Narang Medical Limited, ResMed Inc., and Somnetics International, Inc.

Global Urology Care Devices and Platforms Market: Focus on Product Type, Application, Indication, End User, and Regional Analysis

The post Positive Airway Pressure Devices Market – A Global and Regional Analysis: Focus on Product Type, Indication, End User, Epidemiology, Compliance Rate, Discontinuation, and Regional Analysis – Analysis and Forecast, 2021-2030 first appeared on CRI Report.

Molecular Diagnostics Market Segmentation

• Products (Kits and Consumables, Systems, Software and Other Products)
• Testing Location (Laboratory Testing and Point-of-Care (POC) Testing)
• Application (Core Molecular Diagnostics, Reproductive Genetics, Companion Diagnostics (CDx), Liquid Biopsy, and Others)
• Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Isothermal Nucleic Acid Amplification Technology (INAAT), Microarray, In-situ Hybridization (ISH), Immunohistochemistry (IHC) and Other Technologies)
• End User (Hospitals, Diagnostics Centers, Out-Patient Clinics/General Practitioners, Research Laboratories, and Other End Users)

Regional Segmentation

• North America: U.S., Canada
• Europe: Germany, France, Italy, U.K., Spain, and Rest-of-Europe
• Asia-Pacific: Japan, China, India, Australia, Singapore, and Rest-of-Asia-Pacific
• Latin America: Brazil, Mexico, Rest-of-Latin America
• Rest-of-the-World (RoW)

Market Growth Drivers

• A Highly Increasing Prevalence of Infectious Diseases and Various Types of Cancer, Globally
• Growth in the Biomarker Identification Market and Advancements in Molecular Techniques
• Increase in Awareness and Acceptance of Personalized Medicines on a Global Level
• Significant External Funding for Executing Research and Development Exercises

Market Challenges

• Uncertain Reimbursement Scenario
• Lack of High-Complexity Testing Centers
• Complex Regulatory Frameworks Delaying the Approval of New Molecular Diagnostic Tests

Market Opportunities

• Massive Scope for Adoption of Molecular Diagnostics in Emerging Nations
• Rise of Next-Generation Ultrasensitive Molecular Diagnostics
• Novel Revenue Streams

Key Companies Profiled

Abbott, Agilent Technologies, Inc., Becton, Dickinson and Company (BD), bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher, F. Hoffmann-La Roche Ltd, Guardant Health, HTG Molecular Diagnostics, Inc., Illumina, Inc., Invivoscribe, Inc., ICON plc, LungLife AI, Inc., QIAGEN, QuantuMDx Group Ltd., Siemens Healthcare GmbH, Thermo Fisher Scientific Inc.

Key Questions Answered in this Report:

• How is each segment of the market expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each segment?
• What are the major market drivers, challenges, and opportunities in the global molecular diagnostics market?
• What are the underlying structures resulting in the emerging trends within the global molecular diagnostics market?
• How is each segment of the global molecular diagnostics market expected to grow during the forecast period, and what will be the expected revenue generated by each of the segments by the end of 2031?
• What are the key developmental strategies implemented by the major players to sustain in the competitive market?
• What are the key regulatory implications in developed and developing regions for molecular diagnostics?
• Who are the leading players with significant offerings to the global molecular diagnostics market? What is the current market dominance for each of these leading players?
• What would be the compound growth rate witnessed by the leading players in the market during the forecast period 2021-2031? Which molecular diagnostic product type has the most promising growth?
• What are the key applications in the global molecular diagnostics market? What are the major segments of these applications? What technologies are dominating these application segments?
• What are the major technologies that are employed in the global molecular diagnostics market? Which is the dominating technology?
• Who are the primary end-users of the global molecular diagnostics market? Which is the fastest-growing end-user segment in the global molecular diagnostics market?
• Who are the key manufacturers in the global molecular diagnostics market, and what are their contributions? Also, what is the growth potential of each major molecular diagnostics manufacturer?
• What is the scope of the global molecular diagnostics market in North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World? Which molecular diagnostics application and end user dominate these regions?
• What are the emerging trends in the global molecular diagnostics market? How are these trends revolutionizing the diagnostic procedure?
• Which technologies are anticipated to break through the current molecular diagnostic regime?
• Which companies are anticipated to be highly disruptive in the future and why?
• What are the regulatory procedures that are required to unify the approval process for emerging molecular diagnostics? How will these enhance the reimbursement scenario?
• What are the gaps in regularizing optimum molecular diagnostic adoption in regular healthcare routines? How are these gaps being tackled?

Market Overview

Diagnostic tests provide critical insights at every stage of medical care – right from the genetic tests providing information about personalized cancer treatment to the microbial culture identifying accurate antibiotics against an infection.

The importance of diagnostic tests throughout the entire procedure (i.e., prevention, detection, diagnosis, treatment, and successful management of health conditions) of treating an individual for a particular disease is as consequential as the treatment itself. It has been subjected to extensive research for further refinement of the same.

Our healthcare experts have found the molecular diagnostics market to be one of the stable markets, and the global market is predicted to grow from $10,914.6 million in 2020 to $24,228.0 million in 2031 and is expected to grow with a CAGR of 7.38% during the forecast period 2021-2031.

Factors fueling the growth of the market include a highly increasing prevalence of infectious diseases and various types of cancer, an increase in awareness and acceptance of personalized medicines on a global level, and significant external funding for executing research and development exercises. Despite rapid advanced industry growth, several key issues need to be addressed to facilitate future growth.

Uncertain reimbursement scenarios, lack of high-complexity testing centers, and complex regulatory frameworks delaying the approval of new molecular diagnostic tests are hampering the market growth.

Further, some of the opportunities, such as massive scope for the adoption of molecular diagnostics in emerging nations and the rise of next-generation ultrasensitive molecular diagnostics and novel revenue streams, provide growth to the market.

Within the research report, the market has been segmented based on product, testing location, application, technology, end user, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The exponential rise in the prevalence of infectious diseases and various types of cancer globally has created a buzz among companies to invest in advanced technologies such as molecular diagnostics.

Based on region, North America holds the largest share, owing to improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. However, the Asia-Pacific and Europe regions are anticipated to grow at the fastest CAGR during the forecast period.

Global Influenza Diagnostics Market 2029

The post Molecular Diagnostics Market-Analysis and Forecast,2021-2031 first appeared on CRI Report.

Market Report Coverage – Wiring Harnesses and Connectors for Electric Vehicles Market

Market Segmentation

• Vehicle Type: Passenger, Commercial
• Propulsion Type: Battery Electric Vehicle (BEV), Hybrid Electric Vehicle (HEV), Plug-In Hybrid Electric Vehicle (PHEV)
• Application: Body Harness, High Voltage Battery Harness, Dashboard/Cabin Harness, HVAC Harness, Others
• Product Type: High Voltage, Low Voltage
• Material Type: Copper, Aluminum, Optical Fiber
• Component Type: Wires, Connectors, Others

Regional Segmentation

• North America: U.S., Canada, and Mexico
• Europe: Germany, France, Italy, Spain, and Rest-of-Europe
• U.K.
• China
• Asia-Pacific and Japan: Japan, South Korea, India, and Rest-of-Asia-Pacific and Japan
• Rest-of-the-World (RoW)

Market Growth Drivers

• Growing Adoption of Electric Vehicles
• Deployment of Wide-Scale Charging Infrastructure for Electric Vehicles
• Need for High Voltage Wiring Harnesses for Electric Vehicle Applications
• Growing Need for Automotive Safety Systems

Market Challenges

• Corrosion Susceptibility of Wiring Harnesses and Connectors
• Increase in Copper Prices

Market Opportunities

• Introduction of Autonomy Levels in Electric Vehicles
• Weight Reduction of Wiring Harnesses and Connectors

Key Companies Profiled

Sumitomo Electric Industries, Ltd., Leoni AG, Aptiv PLC, Fujikura Ltd., Kromberg & Schubert GmbH, Coroplast Group, SINBON Electronics Co., Ltd., Korea Electric Terminal Co., Ltd., EG Electronics, LS Cable & System Ltd., TE Connectivity, ACOME, Gebauer & Griller, Continental AG, Lear Corporation

How This Report Can Add Value

Product/Innovation Strategy: The product segment helps the readers in understanding the different types of wiring harnesses used in electric vehicles. Also, the study provides the readers with a detailed understanding of the wiring harnesses and connectors for electric vehicles market by application and product.

Growth/Marketing Strategy: In order to improve the capabilities of their product offerings, players in the wiring harnesses and connectors for electric vehicles market are developing unique products.

The readers will be able to comprehend the revenue-generating tactics used by players in the wiring harnesses and connectors for electric vehicles market by looking at the growth/marketing strategies. Other market participants’ tactics, such as go-to-market plans, will also assist readers in making strategic judgments.

Key Questions Answered in the Report:

• For a new company looking to enter the wiring harnesses and connectors for EVs market, which areas could it focus upon to stay ahead of the competition?
• How do the existing market players function to improve their market positioning?
• Which are the promising companies that have obtained financial support to develop their products and markets?
• How does the supply chain function in the global wiring harnesses and connectors for electric vehicles market?
• Which companies have been actively involved in innovation through patent applications, and which products have witnessed maximum patent applications during the period 2019-2021?
• Which product segment is expected to witness the maximum demand growth in the global wiring harnesses and connectors for electric vehicles market during 2021-2031?
• Which are the players that are catering to the demand for different wiring harnesses and connectors?
• How should the strategies adopted by market players vary for different product segments based on the size of companies involved in each segment?
• What are the key offerings of the prominent companies in the market for wiring harnesses and connectors for electric vehicles?
• What are the demand patterns of wiring harnesses and connectors across the application areas in different regions and countries during the period 2021-2031?

Global Wiring Harnesses and Connectors for Electric Vehicles Market

Wiring harnesses are fundamentally a collection of wires, connectors, relays, fuses, and switches, for transferring electrical signals in a vehicle. They help keep the loose wire securely in the proper place for the safety and well-being of the vehicle. They operate in low and high-voltage conditions.

The wiring harnesses and connectors are gaining traction owing to the growing adoption of electric vehicles, where high voltage wires are increasingly being used for the battery circuit of the vehicle to power the vehicle.

Global Wiring Harnesses and Connectors for Electric Vehicles Industry Overview

The global wiring harnesses and connectors for electric vehicle market is expected to reach $22.87 billion by 2031, with a CAGR of 23.37% during the forecast period 2021-2031. According to recent studies, the rapid advancement in the field of electric vehicles is favoring the increased demand for wiring harnesses and connectors.

Electric vehicles use almost double the amount of wires when compared to a traditional ICE vehicle. Therefore, the weight of wiring in electric vehicles increases. As a consequence, OEMs are readily resorting to aluminum wiring harnesses in order to reduce the weight of wiring harnesses, and in turn, increase the range of their vehicles.

Moreover, the demand for high voltage wires has been ramped up due to the high voltage battery ecosystems in electric vehicles. All of the above-mentioned developments in the wiring harness market have also impacted the market in a positive way, by virtue of which the market is expected to exhibit significant growth over the forecast period (2021-2031).

Market Segmentation

Global Wiring Harnesses and Connectors for Electric Vehicles Market by Propulsion Type

Wiring harnesses and connectors for HEVs generated the most value in 2020 owing to a large number of HEV production in Asia-Pacific and Japan.

Countries such as Japan rely on HEVs for their share in the electric vehicle industry and are one of the largest producers of HEVs through leading companies such as Mitsubishi, Nissan Motor Company, and Honda. However, the market will shift toward BEVs over the forecast period as BEVs use a larger number of wires than HEV.

Also, BEV deploys larger and thicker high voltage wires when compared with HEVs owing to the bigger battery.

Global Wiring Harnesses and Connectors for Electric Vehicles Market by Vehicle Type

Passenger electric vehicles segment is expected to dominate the market throughout the forecast period. It can be directly attributed to the larger number of passenger vehicles when compared to commercial vehicles currently.

However, it is to be noted that commercial vehicles use more wiring harnesses and connectors owing to their larger sizes and complex functions. It will also grow at a faster rate over time as commercial electric vehicles are readily being introduced in the EV domain.

Global Wiring Harnesses and Connectors for Electric Vehicles Market by Application

Body harness occupied the largest share in the market in 2020. The wiring harness used in this system performs various important in electric vehicles, and therefore, has the most value and volume in the market currently. Nevertheless, high voltage battery harness shows a significant increase during the forecast period due to the growing adoption of electric vehicles.

Global Wiring Harnesses and Connectors for Electric Vehicles Market by Product Type

The low voltage wiring harness segment dominates the market, albeit it will be surpassed by high voltage wires for electric vehicles by the end of the forecast period. Low voltage harnesses make up almost 70% of the total wiring harnesses present in an electric vehicle. It is needed for all the auxiliary functions in EVs, such as infotainment systems, doors, seats, HVAC, and engines.

However, the need for high voltage wires is increasing as the adoption of electric vehicles is ramping up.

Global Wiring Harnesses and Connectors for Electric Vehicles Market by Material Type

Electric vehicles use double the amount of copper which is usually required by ICE vehicles. Moreover, all the wires in vehicles are constructed using copper owing to its excellent conductivity and mechanical strength; however, aluminum is emerging as the favorite material for electric vehicle OEMs in order for them to reduce the weight of their vehicles. However, copper will be dominating the market throughout the forecast period.

Wiring Harnesses and Connectors Market for Electric Vehicles Market(by Material Type) , Value, 2020-2031

Global Wiring Harnesses and Connectors for Electric Vehicles Market by Component Type

Wires form the main component of wiring harnesses. Therefore, it will dominate the market throughout the forecast period. Wires are generally made up of copper with one or multiple layers of insulation around them for protection and for prevention of energy loss.

Also, in luxury electric vehicles, a large number of wires are involved for complex electrical functions. Moreover, larger cars tend to use larger and heavier wires in conjunction with connectors to carry out operations.

Global Wiring Harnesses and Connectors for Electric Vehicles Market by Region

China is expected to be the largest market for wiring harnesses and connectors for electric vehicles in 2031, in addition to being the 2nd largest market for wiring harness and connectors for electric vehicles after Asia-Pacific and Japan. The electric vehicle market in China was the largest in terms of volume in 2020 and is expected to increase exponentially.

Therefore, the use of wiring harnesses in China is also increasing. Also, there is a large number of electric vehicles in the commercial fleet of China that have been deployed for cab services. Moreover, China is readily electrifying its existing ICE fleet into electric vehicles, which would deploy additional usage of high voltage wiring harnesses and connectors.

Key Market Players and Competition Synopsis

Sumitomo Electric Industries, Ltd., Leoni AG, Aptiv PLC, Fujikura Ltd., Kromberg & Schubert GmbH, Coroplast Group, SINBON Electronics Co., Ltd., Korea Electric Terminal Co., Ltd., EG Electronics, LS Cable & System Ltd., TE Connectivity, ACOME, Gebauer & Griller, Continental AG, Lear Corporation

The companies profiled in the report have been selected post-in-depth interviews with experts and understanding details of companies such as their product portfolios, annual revenues, market penetration, research and development initiatives, and domestic and international presence in the wiring harnesses and connectors for electric vehicles market.

Electric Vehicle Testing, Inspection, and Certification – A Global and Regional Analysis: Focus on Product, Application, and Country Assessment

The post Wiring Harnesses and Connectors for Electric Vehicles Market – A Global and Regional Market Analysis: Focus on Vehicle Type, Propulsion Type, Application Type, Product Type, Material Type, Component Type, and Regional Analysis – Analysis and Forecast, 2020-2031 first appeared on CRI Report.

Market Segmentation

• Cancer Type – Liver Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer, and Other Cancers
• End User – Hospitals, Ambulatory Surgical Centers, and Others
• Product Type – Ablation Devices (Radiofrequency Ablation, Microwave Ablation, and Cryoablation), Embolization Devices (Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy, Transcatheter Arterial Embolization (TAE)/Bland Embolization), Supporting Devices (Catheters and Guidewires), and Next-Generation Devices (Irreversible Electroporation Ablation, Percutaneous Ethanol Ablation, High Intensity Focused Ultrasound, Laser Ablation, Photothermal Ablation, and Theranostics)

Regional Segmentation

• North America – U.S. and Canada
• Europe – Germany, U.K., France, Italy, and Rest-of-Europe
• Asia-Pacific – Japan, China, India, Australia, and Rest-of-Asia-Pacific
• Rest-of-the-World – Latin America and Middle East and Africa

Market Growth Drivers

• High Prevalence and Growing Incidences of Cancer
• Favorable Reimbursement Scenario for Interventional Oncology Treatment in Developed Economies
• Expanding Role of Interventional Oncology in the Treatment of Cancer
• Availability of Private and Government Funding and Grants for Research in the Field of Interventional Oncology

Market Challenges

• Financial Burden of Product Recalls
• Lack of Clinical Evidence for Locoregional Treatments
• Dearth of Trained Interventional Oncologists

Market Opportunities

• High Growth Opportunity in the Emerging Economies
• Emergence of Local Companies in Asia-Pacific and the Middle East and Africa

Key Companies Profiled

AngioDynamics, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Eckert & Ziegler BEBIG AG, HealthTronics, Inc., IceCure Medical Ltd, Johnson & Johnson, Medtronic plc, MedWaves, Inc., Merit Medical Systems, Inc., Sanarus Technologies, Inc., Sonablate Corp, Terumo Corporation, Trod Medical, Varian Medical Systems, Inc.

How This Report Can Add Value

Assuming that the reader is a manufacturer of interventional oncology devices market, they will be able to do the following:

• Understand their position compared to some of the key players in the market
• Stay updated with novel technology integration, features, and the latest developments in the market
• Understand the impact of COVID-19 on the adoption of interventional oncology devices and the entry barriers because of it
• Gain insights into end-user perception with respect to the adoption of interventional oncology
• Identify some of the key players in the market and understand their valuable contribution

Key Questions Answered in the Global Interventional Oncology Devices Market Report

• What are the key trends that have a strong influence on the global interventional oncology devices market? How did the COVID-19 pandemic impact the growth of the interventional oncology devices market?
• What are the key development strategies which are implemented by the key players to maintain and capture market share?
• How does the patent landscape of interventional oncology devices look like?
• What are the major market drivers, challenges, and opportunities in the global interventional oncology devices market?
• Which leading companies are dominating the global interventional oncology devices market?
• What are the regulations about the global interventional oncology devices market? What are the initiatives implemented by different government bodies to reduce the cancer rate?
• What was the market value of the leading segments and sub-segments of the global interventional oncology devices market?
• How is each segment of the global interventional oncology devices market expected to grow during the forecast period, and what is the expected revenue to be generated by each of the segments by the end of 2030?
• Which region carries the potential for the significant expansion of key companies for the interventional oncology devices market?

Global Interventional Oncology Devices Market Industry Overview

Interventional oncology procedures are suitable for those cancer patients who do not respond to chemotherapy and are not fit for surgery. Interventional oncology procedures require devices such as embolization and ablation devices, as well as an array of support devices such as catheters.

The global interventional oncology devices market is an emerging market in the medical device ecosystem. The market comprises various key medical device companies and several start-ups developing advanced solutions for cancer treatment. Furthermore, the market also has unique products in the pipeline that would further improve the technology integration in cancer treatment. The major factors that have a positive impact on the market’s growth include high prevalence and growing incidences of cancer, favorable reimbursement scenario for interventional oncology treatment in developed economies, expanding role of interventional oncology in treatment of cancer, and availability of private and government funding for grants for research in the field of interventional oncology.

During COVID-19, the growth of the interventional oncology devices market was negatively impacted, especially in 2020. Although the interventional oncology facilities continued to operate, the sales of the companies were negatively impacted.

The global interventional oncology devices market report highlights that the market was valued at $2,429.2 million in 2020 and is expected to reach $7,861.1 million by the end of 2030. The market is expected to grow at a CAGR of 12.35% during the forecast period from 2021 to 2030.

Global Interventional Oncology Devices Market Drivers

The factors driving the growth of the market include the high prevalence and growing Incidences of cancer, favorable reimbursement scenario for interventional oncology treatment in developed economies, expanding role of interventional oncology in the treatment of cancer, availability of private and government funding and grants for research in the field of interventional oncology. The field of interventional oncology is constantly evolving with the introduction of novel technologies. Governments invest a significant amount of money in healthcare insurance so that the overall healthcare costs can be reduced, and the quality of life and affordability of the treatment can be enhanced.

Thus, as the prevalence of cancer continues to increase, especially in emerged economies, technology adoption will continue to grow. This will consequently advance the growth of interventional oncology and, subsequently, the global market.

Global Interventional Oncology Devices Market Challenges

The factors restraining the growth of the global interventional oncology devices market include the financial burden of product recalls, the lack of clinical evidence for locoregional treatments, and the dearth of trained interventional oncologists. Shortage of clinical data and increasing incidences of serious side effects associated with the use of interventional oncology devices have led to numerous instances of interventional oncology device product recalls that are critically hindering the growth of the interventional oncology devices market.

Another major restraint for the global interventional oncology devices market is the shortage of skilled interventional oncology professionals in most countries who can perform interventional oncology procedures. The situation continues to worsen, as cancer is rising faster than the rate at which new interventional oncologists are entering the field.

Global Interventional Oncology Devices Market Opportunities

High growth opportunities in the emerging economies and the emergence of local companies in Asia-Pacific and the Middle East and Africa hold immense potential for the global interventional oncology devices market growth.

There is massive scope for interventional oncology devices in developing countries. Countries such as China, India, Australia, and South Korea possess populations with high prevalence and incidence rates of cancer, which drives the adoption of interventional oncology devices for the treatment of cancer, which would surge the overall interventional oncology devices market in these emerging countries.

Impact of COVID-19 on the Global Interventional Oncology Devices Market

During COVID-19, the growth of the interventional oncology devices market was negatively impacted, especially in 2020. Although the interventional oncology facilities continued to operate, the sales of the companies were negatively impacted. Nonetheless, the market grew minimally in 2020 and is projected to witness considerable growth during the forecast period 2021-2030. The increasing technological innovations in the global market and growing adoption in emerging economies are the factors for the growth of the market.

Market Segmentation

Global Interventional Oncology Devices Market (by Cancer Type)

The global interventional oncology devices market, on the basis of cancer type, has been segmented into liver cancer, lung cancer, kidney cancer, prostate cancer, and other cancer.

The liver cancer segment accounted for the highest share of the market, which can be attributed to high consumption of alcohol, chronic viral hepatitis, liver cirrhosis, and rise in the obesity index globally. Moreover, liver cancer is less common in the U.S. than in sub-Saharan Africa and South Asian countries. Liver cancer accounts for more than 70,000 deaths each year.

Global Interventional Oncology Devices Market (by Product Type)

The global interventional oncology devices market, on the basis of product type, has been segmented into ablation devices, embolization devices, supporting devices, and next-generation devices.

Ablation is used as the first line of treatment in a few cases of hepatocellular carcinoma, and it is also considered an important option for patients who are either not eligible for surgery or have failed chemotherapy. Furthermore, advancements in interventional oncology would propel the growth of next-generation devices in the forecast period 2021-2030.

Global Interventional Oncology Devices Market (by End User)

The global interventional oncology devices market, on the basis of end users, has been segmented into three categories, namely, hospitals, ambulatory surgical centers (ASCs), and others.

Hospitals are at the forefront in terms of interventional oncology devices adoption. The increasing focus on evidence-based care has been one of the strongest drivers for the adoption of interventional oncology.

The growing prominence for outpatient surgeries and rising establishments of ASCs are the leading factors promoting the market’s growth for the global interventional oncology devices. The adoption of interventional oncology devices in ambulatory surgical centers can be boosted by prioritizing the increasing demand for minimally invasive surgeries.

Global Interventional Oncology Devices Market (by Region)

The different regions covered under the global interventional oncology devices market include North America, Europe, Asia-Pacific, and Rest-of-the-World.

North America dominates the global interventional oncology devices market due to high prevalence of cancer, growing geriatric population, and high reimbursement rates. The Asia-Pacific interventional oncology devices market is one of the lucrative markets with immense potential for expansion by key players of the global interventional oncology market. The Asia-Pacific interventional oncology devices market is expected to grow at the fastest rate in the forecast period, and this can be attributed to the massive geriatric population base, driving the demand for minimally invasive and non-invasive surgical procedures.

Key Market Players and Competition Synopsis

Some of the key players operating in the market include AngioDynamics, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Eckert & Ziegler BEBIG AG, HealthTronics, Inc., IceCure Medical Ltd, Johnson & Johnson, Medtronic plc, MedWaves, Inc., Merit Medical Systems, Inc., Sanarus Technologies, Inc., Sonablate Corp, Terumo Corporation, Trod Medical, and Varian Medical Systems, Inc.

Some of the strategies covered in this segment are funding activities, mergers and acquisitions (M&As), partnerships, alliances, and business expansion, regulatory and legal activities, and new offerings. The preferred strategy for companies has been mergers and acquisitions followed by regulatory and legal activities.

Global Microcatheters Market: Increasing prevalence of chronic diseases such as neurovascular and cardiovascular disorders is expected to augment the market at a healthy CAGR of ~4.1% during the forecast period of 2020 to 2027

The post Interventional Oncology Devices Market – A Global and Regional Analysis: Focus on Cancer Type, Product Type, End Users, and Country-Wise Analysis – Analysis and Forecast, 2021-2030 first appeared on CRI Report.

Market Segmentation

• Product Type – Conventional Microscopes and Advanced Microscopes
• Application – ENT, Ophthalmology, Dental, Neurology, Gynecology, Spine, and Plastic and Reconstructive
• End Users – Hospitals and Physician Clinics and Other Settings
• Region – North America, Europe, Asia Pacific, Latin America, and Middle East and Africa

Regional Segmentation

• North America – U.S. and Canada
• Europe – Germany, U.K., France, Italy, Spain, Russia, Nordic Countries, Benelux Countries and Rest-of-Europe
• Asia-Pacific – China, Japan, South Korea, India, Australia and New Zealand, and Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, Argentina, Rest-of-Latin-America
• Middle East and Africa – KSA, South Africa, U.A.E., Rest-of-Middle East-and-Africa

Market Growth Drivers

• Increasing Use of Fluorescence Image-Guided Surgery (FIGS)
• Rising Minimally Invasive Surgical Procedures on the Global Level

Market Challenges

• Low Adoption Rate Due to High Cost of Surgical Microscopes
• Lack of Skilled Professionals with Limited Technical Knowledge

Market Opportunities

• 3D Exoscopes ~ An Optical Innovation

Key Companies Profiled

Alcon, Inc., B. Braun Melsungen AG, BHS Technologies GmbH, Carl Zeiss Meditech AG, Haag-Streit Holding AG (Metall Zug AG), Karl Storz SE & Co. KG, Danaher Corporation (Leica Microsystems GmbH), Munich Surgical Imaging GmbH, Olympus Corporation, Synaptive Medical, Inc., Topcon Corporation

How This Report Can Add Value and Who should buy this report?

• Surgical Microscopes manufacturers (emerging and established)
• Established technology companies
• Hybrid OT manufacturers
• Healthcare facilities

Key Questions Answered in the Global Surgical Microscopes Market Report

• How has the COVID-19 pandemic impacted the global surgical microscopes market?
• What is the regulatory landscape of the global surgical microscopes market? How have the regulations altered due to the COVID-19 pandemic?
• What has been the patent landscape for the market during 2017-2021?
• What are the major companies operating in the market and their respective market share?
• What are the major strategies employed by the companies to enter the market or for business expansion?
• How are advanced microscopes different from conventional microscopes?
• What are the major industry trends, market drivers, and market restraints that would impact the market during the forecast period 2021-2031? What are the growth opportunities for the market?
• Which product type, application, and end-user segment are expected to dominate the market during the forecast period 2021-2031?
• What would be the country-level revenue share and CAGR for the market during the forecast period 2021-2031?

Surgical Microscopes Overview

Although the compound microscope was invented in 1590 and was used for the examination of wounds and scars in the late 17th century, it had several limitations, including its heavy weight, large size, and poor image quality due to chromatic and spherical aberrations.

Ernst Abbe proposed numerical aperture in the late 1800s, which substantially improved microscope resolution. Later, the monocular and binocular microscopes were combined with tripods and light sources and employed for a variety of examinations.

Surgical microscopes had been honed to be a precise tool with a number of enticing characteristics at the time. They have high-precision optics and high-power coaxial illumination, allowing surgeons to alter magnifications, work at the right distance, and see the entire operating field unimpeded.

Surgical microscopes have been used in a variety of surgeries, including neuro and spine surgery, ENT surgery, dentistry, ophthalmology, and plastic and reconstructive surgery, due to numerous advantages such as clear and bright visualization, easy documentation and adaptation, stability, maneuverability, and improved ergonomics.

The surgical microscopes market report highlights that the overall surgical microscopes market was valued at $928.3 million in 2020 and is expected to reach $3,578.2 million by the end of 2031. The market is expected to grow at a CAGR of 13.3% during the forecast period from 2021 to 2031.

Surgical Microscopes Market Dynamics

Advancements and developing technologies are currently paving the way and establishing their presence in the global surgical microscopes market. With the introduction of modern technologies that can be easily employed in hospitals and physician clinics, there is tremendous potential for these developing and new technologies to enhance the overall growth of the market.

Operative microscopes are increasingly being employed in operating rooms because they enable adjustable magnification, excellent illumination, and provide a clear view of the surgical field. For image-guided surgery, cutting-edge surgical microscopes are combined with imaging modalities such as optical coherence tomography (OCT), fluorescence imaging, and augmented reality (AR).

Some of the domains where surgical or operating microscopes are used are ENT, dental, neurology, plastic and reconstructive, and gynecology. It has been observed in recent times that patients are shifting toward minimally invasive surgeries due to the various advantages offered by MIS, like scarless technology, shorter hospital stay, and a few others.

Also, rising end-user preference for non-invasive diagnostic technologies over invasive technologies is expected to drive the market during 2021-2031.

Surgery is a primary therapeutic approach for a variety of disorders, including cancer. A clear vision of the anatomical features is one of the most important factors for surgeons to work accurately. This, however, has never been easy.

On the one hand, some anatomical structures are extremely small (millimeters to microns), and they may be near other organs or tissue. A resolution far beyond that of human vision is required to see these structures clearly.

The lack of illumination in narrow cavities and deep channels, which are typical in neurosurgery, ENT surgery, and endodontics, leads to dull visibility with shadows. Poor visualization may result in an inadvertent operation on anatomical structures or a nearby organ, affecting the surgical outcome, reducing organ preservation, or possibly posing a life-threatening risk.

As a result, adequate magnification and optimum illumination are critical for surgical success. All these factors are expected to boost the market for surgical microscopes.

For various companies, growth is expected to be driven by rising demand for better accuracy and clearer images, as well as better precision during surgeries. The global surgical microscopes market is predicted to rise as a result of these improvements in multimodal diagnostic imaging for various surgical procedures.

Impact of COVID-19 on Surgical Microscopes

Surgical microscopes are frequently used in minimally invasive surgical operations, and the growing desire for MIS treatments has played a crucial role in the healthcare business in recent decades, with the number of MIS procedures increasing significantly in the last five years.

In the first half of 2020, the COVID-19 pandemic had a significant influence on elective surgical procedures. On a global scale, the COVID-19 pandemic had a significant influence on regular hospital routine services. During the early stages of the pandemic, hospitals drastically restricted or stopped performing elective surgical procedures to ensure patient safety and to focus on COVID19 patients.

The large-scale decline in the volume of elective surgical procedures had a significant impact on patients as well as financial consequences for medical device producers. As a result, sales of minimally invasive surgical equipment have declined.

Market Segmentation

Surgical Microscopes Market (by Product Type)

Different technologies that have been studied and analyzed under the surgical microscopes market report include conventional microscopes and advanced microscopes.

Conventional microscopes generate the highest revenue in the surgical microscopes market, and advanced microscopes are expected to rise at a faster pace between 2021 and 2031. This is mostly due to a rise in technologically advanced options and features like the incorporation of LED lights, better visualization, and precision.

Surgical Microscopes Market (by Application)

Different applications that have been studied and analyzed under the surgical microscopes market report include ENT, dental, ophthalmology, neurology, gynecology, spine, and plastic and reconstructive.

In the surgical microscopes market, the ENT segment generates the most revenue, while plastic and reconstructive is projected to expand at the fastest rate between 2021 and 2031. The plastic and reconstructive segment is projected to grow at the fastest rate because of the growing demands for plastic and reconstruction surgeries across the globe.

Surgical Microscopes Market (by Region)

The different regions covered under the surgical microscopes market report include North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.

North America dominated the global surgical microscopes market in 2020 and is anticipated to uphold its dominance throughout the forecast period. The growth in the market is majorly driven by the increasing adoption of surgical microscopes by surgeons in various medical fields such as neurology, ENT, ophthalmology, gynecology, etc. Also, the ongoing trend for the rise in demand for multi-modality imaging is putting a significant impact on the market growth.

Key Market Players and Competition Synopsis

Some of the key players operating in the market include Alcon, Inc., B. Braun Melsungen AG, BHS Technologies GmbH, Carl Zeiss Meditech AG, Haag-Streit Holding AG (Metall Zug AG), Karl Storz SE & Co. KG, Danaher Corporation (Leica Microsystems GmbH), Munich Surgical Imaging GmbH, Olympus Corporation, Synaptive Medical, Inc., and Topcon Corporation.

The surgical microscopes market has witnessed several strategic and technological developments in the past few years, undertaken by the different market players to attain their respective market shares in this emerging domain.

Some of the strategies covered in this segment are new offerings and upgradation, collaborative activities (partnerships, alliances, and business expansions, mergers and acquisitions), and regulatory and legal activities. The preferred strategy for companies has been new offerings and upgradation.

Key Highlights

• According to the surgical microscopes market report, conventional microscopes dominated the market in 2020 compared to emerging microscopes under the product type segmentation. Conventional microscopes are forecast to uphold this position in the market and dominate till the end of the forecast period 2021-2031.
• When the market is segmented by application, ENT is the market leader. By the end of the forecast period 2021-2031, the plastic and reconstructive segment is projected to lead the market.
• Conventional microscopes accounted for an 83.8% share of the total market.
• Surgical Microscopes hold the highest numbers in the North America region followed by Europe. The U.S. led the table by contributing 84.1% of the total market in 2020. It is expected that by the end of the forecast period 2021-2031, North America will continue to lead the region-based segmentation.

China Surgical Microscopes for Neurosurgical Operation Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

The post Surgical Microscopes Market – A Global and Regional Analysis: Focus on Product Type, Application, End User, 25 Countries’ Data, Patent Scenario, and Competitive Landscape – Analysis and Forecast, 2021-2031 first appeared on CRI Report.